CN106094248A - A kind of eye glass frame containing negative oxygen ion and processing technique thereof - Google Patents
A kind of eye glass frame containing negative oxygen ion and processing technique thereof Download PDFInfo
- Publication number
- CN106094248A CN106094248A CN201610712053.5A CN201610712053A CN106094248A CN 106094248 A CN106094248 A CN 106094248A CN 201610712053 A CN201610712053 A CN 201610712053A CN 106094248 A CN106094248 A CN 106094248A
- Authority
- CN
- China
- Prior art keywords
- content
- oxygen ion
- negative oxygen
- glass frame
- eye glass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000001301 oxygen Substances 0.000 title claims abstract description 100
- 229910052760 oxygen Inorganic materials 0.000 title claims abstract description 100
- 239000011521 glass Substances 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title claims abstract description 31
- 239000000843 powder Substances 0.000 claims abstract description 64
- 239000004033 plastic Substances 0.000 claims abstract description 25
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000004568 cement Substances 0.000 claims abstract description 22
- 229910052719 titanium Inorganic materials 0.000 claims abstract description 22
- 239000010936 titanium Substances 0.000 claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 19
- -1 oxygen ion Chemical class 0.000 claims description 94
- 230000008569 process Effects 0.000 claims description 15
- 238000002347 injection Methods 0.000 claims description 12
- 239000007924 injection Substances 0.000 claims description 12
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 10
- 229910052681 coesite Inorganic materials 0.000 claims description 10
- 229910052593 corundum Inorganic materials 0.000 claims description 10
- 229910052906 cristobalite Inorganic materials 0.000 claims description 10
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 10
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 10
- 239000000377 silicon dioxide Substances 0.000 claims description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- 229910052682 stishovite Inorganic materials 0.000 claims description 10
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titanium dioxide Inorganic materials O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 10
- 229910052905 tridymite Inorganic materials 0.000 claims description 10
- 229910001845 yogo sapphire Inorganic materials 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 6
- 239000003973 paint Substances 0.000 claims description 6
- 238000004080 punching Methods 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 6
- 235000019628 coolness Nutrition 0.000 claims 1
- 230000002045 lasting effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 12
- 201000010099 disease Diseases 0.000 abstract description 11
- 208000001491 myopia Diseases 0.000 abstract description 7
- 230000004379 myopia Effects 0.000 abstract description 7
- 201000010041 presbyopia Diseases 0.000 abstract description 7
- 230000001225 therapeutic effect Effects 0.000 abstract description 7
- 150000003254 radicals Chemical class 0.000 abstract description 4
- 230000004089 microcirculation Effects 0.000 abstract description 3
- 230000003449 preventive effect Effects 0.000 abstract description 3
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 5
- 208000003464 asthenopia Diseases 0.000 description 4
- 208000002177 Cataract Diseases 0.000 description 3
- 235000002673 Dioscorea communis Nutrition 0.000 description 3
- 241000544230 Dioscorea communis Species 0.000 description 3
- 208000010412 Glaucoma Diseases 0.000 description 3
- 208000035753 Periorbital contusion Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 2
- 208000017442 Retinal disease Diseases 0.000 description 2
- 206010038923 Retinopathy Diseases 0.000 description 2
- 206010040954 Skin wrinkling Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000009978 visual deterioration Effects 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000127225 Enceliopsis nudicaulis Species 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 208000007613 Shoulder Pain Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000002061 histotrophic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- BABMCXWQNSQAOC-UHFFFAOYSA-M methylmercury chloride Chemical compound C[Hg]Cl BABMCXWQNSQAOC-UHFFFAOYSA-M 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 208000005494 xerophthalmia Diseases 0.000 description 1
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C5/00—Constructions of non-optical parts
- G02C5/008—Spectacles frames characterized by their material, material structure and material properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C5/00—Constructions of non-optical parts
- G02C5/001—Constructions of non-optical parts specially adapted for particular purposes, not otherwise provided for or not fully classifiable according to technical characteristics, e.g. therapeutic glasses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
Landscapes
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Ophthalmology & Optometry (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Glass Compositions (AREA)
Abstract
The invention provides a kind of eye glass frame containing negative oxygen ion and processing technique thereof.Plastic cement titanium and negative oxygen ion powder should be included containing the eye glass frame of negative oxygen ion；Wherein, being calculated in mass percent, the content of described negative oxygen ion powder is 1%～20%.The negative oxygen ion powder powder that the present invention provides comes from nature mine.Its composition is that multiple element mixes.Far infrared that the eye glass frame that this kind of negative oxygen ion powder is made contains 6～14 μ wavelength and 1100/cm3Negative oxygen ion.This eye glass frame to eye outside disease have more significantly auxiliary therapeutic action；The disease of ophthalmic also there is more significantly auxiliary therapeutic action.Particularly with having presbyopia and the user of myopia, presbyopia and the myopia with stable user do not develop, and the effect alleviated；Can also effectively improve the microcirculation of surrounding orbital tissue, supplementing negative oxygen ion all has preferable preventive effect to free radical resisting, outer for eye and ophthalmic disease.
Description
Technical field
The present invention relates to new material processing technique field, in particular to a kind of eyeglass containing negative oxygen ion
Frame and processing technique thereof.
Background technology
Owing to social rhythm accelerates, use computer, the people of mobile phone get more and more, and the radiation of computer cell phone is plus free radical
Attack and make the eyes of people that various diseases to occur.Such as eyestrain.Eyestrain is a kind of ophthalmology common disease, the eye that it is caused
Do, eye is puckery, eye is sour swollen, and blurred vision even visual deterioration directly affects work and the life of people.Eyestrain mainly due to
When people concentrate to see computer screen at ordinary times, eyes number of winks reduces, and causes tear Secretion to reduce, flashes glimmering simultaneously
Shield intense stimulus eyes and cause.It can cause the corresponding sites such as the neck of people, shoulder pain occur, also can cause and increase the weight of various
Oculopathy.There is also visual deterioration, presbyopia or myopia, eyestrain, xerophthalmia, glaucoma, cataract, black eye, eye pouch, fish tail
Stricture of vagina etc..Similar Problems emerges in an endless stream, and corresponding medical treatment cost increases day by day.
Since 19 the end of the century Germany scientist Philips Silvio Leonard doctor demonstrate anion to human body academicly
Effect, 20 beginning of the century Aschkinass and Caspan certainly negative aeroions biological significance since, people just start to close
The existence of air injection anion and effect, the effect of anion is broadly divided into following two aspects:
(1) environmental protection: the oxygen molecule capturing an electronics is referred to as negative oxygen ion.Scientific research finds, a lot of in air
Harmful gas material is positively charged, and such as antibacterial, dust, smog etc., negative oxygen ion can combine with these harmful substances, plays
Sterilization and elimination abnormal flavour etc. purify the effect of air.World Health Organization (WHO) specifies that the standard of fresh air is, in air negative oxygen from
The concentration of son is more than 1500/cm3。
(2) health care: health and ecology are had heavily by medical circle expert by clinical practice checking negative oxygen ion both at home and abroad
Big impact.Medical research proves: negative oxygen ion has 18% to be to be absorbed by the respiratory tract of people, 82% inhaled by human body by skin
Receive.When in air, the concentration of negative oxygen ion reaches 5000～50000/cm3Time, negative oxygen ion intravasation and lymph are transported to
Whole body, plays setting up, make that autonomic nervous system is stable, effect of enhancing human body immunity power.
Far infrared is the one in sunray in numerous invisible rays, and its medium wavelength is the one of 4～14 mum wavelengths
Section is referred to as the light wave of life, has therapeutical effect.The basis of far-infrared therapeutic effect is thermogenetic effect.In infrared ray radiation
Under, tissue temperature raises, telangiectasis, and blood flow is accelerated, and substance metabolism strengthens, and tissue cell activity and regeneration capacity carry
High.During far-infrared therapeutic chronic inflammatory disease, blood circulation can be improved, increase the phagocytic function of cell, eliminate swelling, promote inflammation
Disease is dissipated.Far infrared can reduce neural irritability, has analgesia, releases striped muscle and smooth muscle spasm and promote god
Act on through functional rehabilitation etc..When treating chronic infective wound and chronic ulcer, improve histotrophic nutrition, eliminate granulation edema,
Promote granulation growth, accelerate wound healing.Far infrared irradiates and is reduced the effect that burn wound oozes out.Far infrared is the most frequent
For treating bruise, promote that tissue edema and hematoma dissipate and alleviate tissue adhesion, promote that cicatrix softens, alleviate cicatrix contraction
Contracting etc..
Summary of the invention
In view of this, a kind of eye glass frame containing negative oxygen ion of the present invention, including plastic cement titanium and negative oxygen ion powder；Its
In, it being calculated in mass percent, the content of described negative oxygen ion powder is 1%～20%.
In some embodiments, including plastic cement titanium and negative oxygen ion powder；Wherein, it is calculated in mass percent, described negative
The content of oxonium ion powder is 2%～10%.
In some embodiments, including plastic cement titanium and negative oxygen ion powder；Wherein, it is calculated in mass percent, described negative
The content of oxonium ion powder is 3%～6%.
In some embodiments, it is calculated in mass percent, in described negative oxygen ion powder:
Al2O3Content be 33%～38%
SiO2Content be 32%～36%
B2O3Content be 9%～13%
The content of MgO is 2%～6.5%
Fe2O3Content be 8%～12%
Na2The content of O is 0.7%～1.1%
K2The content of O is 0.01%～0.08%
The content of CaO is 0.5%～1.0%
P2O5Content be 0.1%～0.3%
TiO2Content be 0.1%～0.3%
The content of FeO is 0.9%～1.5%.
In some embodiments, it is calculated in mass percent, in described negative oxygen ion powder:
Al2O3Content be 35%～36%
SiO2Content be 34%～35%
B2O3Content be 10%～11%
The content of MgO is 4%～5%
Fe2O3Content be 10%～11%
Na2The content of O is 0.85%～1.0%
K2The content of O is 0.03%～0.05%
The content of CaO is 0.7%～0.9%
P2O5Content be 0.15%～0.25%
TiO2Content be 0.2%～0.3%
The content of FeO is 1.2%～1.4%.
In some embodiments, the granularity of described negative oxygen ion powder is 1100～1300 mesh.
In some embodiments, the granularity of described negative oxygen ion powder is 1200～1280 mesh.
Present invention also offers the processing technique of a kind of eye glass frame containing negative oxygen ion, comprise the following steps:
S10: add negative oxygen ion powder, mix homogeneously in plastic cement titanium；
S20: modeling.
In some embodiments, also include after modeling:
S30: deburring, polish, spray paint, polish, pack.
In some embodiments, in described step S20 modeling process particularly as follows: in plastic cement titanium add negative oxygen ion powder mix
Note in punching block by injection machine after closing uniformly, be heated up to 100～130 DEG C and continue depanning, cooling in 30～50 seconds.
A kind of eye glass frame containing negative oxygen ion that the present invention provides and processing technique thereof compared with prior art, tool
There is a following advantage:
(1) the negative oxygen ion powder powder that the present invention provides comes from nature mine.Its composition is that multiple element mixes.
Far infrared that the eye glass frame that this kind of negative oxygen ion powder is made contains 6～14 μ wavelength and 1100/cm3Negative oxygen ion.Should
Eye glass frame containing negative oxygen ion to eye outside disease (such as black eye, eye pouch, crows-feet length) have more significantly auxiliary to control
Treatment effect；The disease (such as glaucoma, cataract, retinopathy etc.) of ophthalmic also there is more significantly auxiliary therapeutic action.Especially
It is for having presbyopia and the user of myopia, and presbyopia and the myopia with stable user do not develop, and the effect alleviated；
(2) present invention use negative oxygen ion powder both can releasing far infrared can also releasing negative oxygen ion, can be effective
The microcirculation improving surrounding orbital tissue, supplement negative oxygen ion to free radical resisting, outer for eye and ophthalmic disease all has
Preferably preventive effect.
In sum, should have preferable market prospect by the eye glass frame containing negative oxygen ion, and reduce corresponding medical treatment and become
While Ben, be suitable to daily long periods of wear and use, use process simple, convenient.To get their way into people's lives widely.
Accompanying drawing explanation
It should be appreciated that the following drawings illustrate only certain embodiments of the present invention, therefore it is not construed as model
The restriction enclosed, for those of ordinary skill in the art, on the premise of not paying creative work, it is also possible to according to these
Accompanying drawing obtains the accompanying drawing that other are relevant.
Fig. 1 is the processing process figure of the glasses that the present invention contains negative oxygen ion.
Detailed description of the invention
The claim of the present invention is described in further detail by the mode below in conjunction with specific embodiment, but not structure
Becoming any limitation of the invention, the amendment of anyone limited number of time made within the scope of the invention as claimed, still at this
Within bright right.
The invention provides a kind of eye glass frame containing negative oxygen ion, including plastic cement titanium and negative oxygen ion powder；Wherein,
Being calculated in mass percent, the content of described negative oxygen ion powder is 1%～20%.
It is above-mentioned, it is to be understood that TR-90 (plastic cement titanium) is a kind of macromolecular material with Memorability, there is ultra-toughness
Property, the features such as crashworthiness is wear-resisting, and coefficient of friction is low, can effectively prevent at the volley, because eyes and face are made by mirror holder fracture, friction
The injury become.Because of the molecular structure that it is special, chemical resistance is good, is unlikely to deform in an environment of high temperature, is resistant to 350 in the short time
Degree high temperature, is difficult to fusing and burning.
Furthermore, plastic cement titanium discharges without chemical residue, meetsEuropeRequirement to food grade materials.TR90 mirror holder surface is moistened
Sliding, density 1.14～1.15, being placed on saline can float, lighter than other plastic spectacle frames, about less than the half of plank material frame weight, is
The 85% of nylon material, can reduce the bridge of the nose, ear burden, be suitable for teenager and use.The product that TR90 material is made is wear-resisting, anti-ization
The property learned is good, solvent resistance, against weather are good, nonflammable, high temperature resistant.TR90 is the macromolecular material of Memorability, and resistance to deformation refers to
Number 620kg/cm2, it is unlikely to deform.
It is understood that the mirror holder of TR-90, temple pattern is various, and stamp is attractive in appearance.
It is to be appreciated that TR90 is in the course of processing, need to fully be dried to moisture content and be less than 0.1%, otherwise injection is squeezed
Go out the goods formed out will turn white (gas white haze), turn to be yellow, foam, Yin Wen, embrittlement, appearance is ugly, mechanical degradation, and
Material loss is big；It is preferably used dehumidifying heat pump (dried for malaria, then sending such as drying machine) the air band being dried
Walking the moisture in raw material, the products appearance of such molding, performance are qualified；Without dehumidifying heat pump, should select fine,
Just produce when air humidity is less than 50%；If be dried fully, plastic still turn white, the injection temperature of barrel should be improved, make former
Material fully plasticizing；
During TR90 injection, should be dried 2～4 hours dehumidifying heat pump 90～less than 110 DEG C.
If mold filling is discontented with during injection: raising gun barrel temperature 10～15 DEG C, the most improve injection pressure and speed, in order to avoid producing
Unboiled water flower；Haze if plastic turns white, barrel temperature 10～15 DEG C, pressure 70～100mpa, speed middling speed should be improved, make aerofluxus good
Good.
It is to be appreciated that negative oxygen ion powder powder comes from nature mine.Its composition is that multiple element mixes.Should
Far infrared that the eye glass frame that kind of negative oxygen ion powder is made contains 6～14 μ wavelength and 1100/cm3Negative oxygen ion.This contains
Disease (such as black eye, eye pouch, crows-feet length) outside having the eye glass frame of negative oxygen ion to eye has and the most significantly assists treatment
Effect；The disease (such as glaucoma, cataract, retinopathy etc.) of ophthalmic also there is more significantly auxiliary therapeutic action.Especially
For having presbyopia and the user of myopia, presbyopia and the myopia with stable user do not develop, and the effect alleviated；
It is to be appreciated that negative oxygen ion powder both can releasing far infrared can also releasing negative oxygen ion, can be effective
The microcirculation improving surrounding orbital tissue, supplement negative oxygen ion to free radical resisting, outer for eye and ophthalmic disease all has
Preferably preventive effect.
Further, including plastic cement titanium and negative oxygen ion powder；Wherein, it is calculated in mass percent, described negative oxygen ion powder
Content be 2%～10%.
Further, including plastic cement titanium and negative oxygen ion powder；Wherein, it is calculated in mass percent, described negative oxygen ion powder
Content be 3%～6%.
Further, Al2O3Content be 33%～38%
SiO2Content be 32%～36%
B2O3Content be 9%～13%
The content of MgO is 2%～6.5%
Fe2O3Content be 8%～12%
Na2The content of O is 0.7%～1.1%
K2The content of O is 0.01%～0.08%
The content of CaO is 0.5%～1.0%
P2O5Content be 0.1%～0.3%
TiO2Content be 0.1%～0.3%
The content of FeO is 0.9%～1.5%.
Further, it is calculated in mass percent, in described negative oxygen ion powder:
Al2O3Content be 35%～36%
SiO2Content be 34%～35%
B2O3Content be 10%～11%
The content of MgO is 4%～5%
Fe2O3Content be 10%～11%
Na2The content of O is 0.85%～1.0%
K2The content of O is 0.03%～0.05%
The content of CaO is 0.7%～0.9%
P2O5Content be 0.15%～0.25%
TiO2Content be 0.2%～0.3%
The content of FeO is 1.2%～1.4%.
Further, the granularity of described negative oxygen ion powder is 1100～1300 mesh.
Further, the granularity of described negative oxygen ion powder is 1200～1280 mesh.
Present invention also offers the processing technique of a kind of eye glass frame containing negative oxygen ion, comprise the following steps:
S10: add negative oxygen ion powder, mix homogeneously in plastic cement titanium；
S20: modeling.
Further, also include after modeling:
S30: deburring, polish, spray paint, polish, pack.
Further, after in described step S20, modeling process is particularly as follows: add negative oxygen ion powder mix homogeneously in plastic cement titanium
Note in punching block by injection machine, be heated up to 100～130 DEG C and continue depanning, cooling in 30～50 seconds.
For the ease of understanding the present invention, further illustrate technical scheme below in conjunction with embodiment.Applicant
Statement, the present invention illustrates detailed process equipment and the technological process of the present invention by above-described embodiment, but the present invention not office
It is limited to above-mentioned detailed process equipment and technological process, does not i.e. mean that the present invention has to rely on above-mentioned detailed process equipment and technique
Flow process could be implemented.Person of ordinary skill in the field is it will be clearly understood that any improvement in the present invention, each to product of the present invention
The equivalence of raw material is replaced and the interpolation of auxiliary element, concrete way choice etc., all falls within protection scope of the present invention and disclosure
Within the scope of.
Embodiment 1
The present invention provides the processing technique of a kind of eye glass frame containing negative oxygen ion, and detailed process is:
S10: adding negative oxygen ion powder in plastic cement titanium, wherein, be calculated in mass percent, the content of negative oxygen ion powder is
1%, it is calculated in mass percent, in negative oxygen ion powder:
Al2O3Content be 38%
SiO2Content be 36%
B2O3Content be 13%
The content of MgO is 2%
Fe2O3Content be 8%
Na2The content of O is 0.7%
K2The content of O is 0.01%
The content of CaO is 1.0%
P2O5Content be 0.3%
TiO2Content be 0.3%
The content of FeO is 0.69%；
The granularity of negative oxygen ion powder is 1100 mesh mix homogeneously；
S20: modeling.
Embodiment 2
The present invention provides the processing technique of a kind of eye glass frame containing negative oxygen ion, and detailed process is:
S10: adding negative oxygen ion powder in plastic cement titanium, wherein, be calculated in mass percent, the content of negative oxygen ion powder is
1%, it is calculated in mass percent, in negative oxygen ion powder:
Al2O3Content be 33%
SiO2Content be 35%
B2O3Content be 9%
The content of MgO is 6.5%
Fe2O3Content be 12%
Na2The content of O is 1.1%
K2The content of O is 0.08%
The content of CaO is 0.5%
P2O5Content be 0.1%
TiO2Content be 0.1%
The content of FeO is 2.62%；The granularity of negative oxygen ion powder is 1300 mesh mix homogeneously；Mix homogeneously；
S20: note in punching block by injection machine by the mixture in step S10, is heated up to 100 DEG C and continues to go out for 30 seconds
Mould, cooling..
S30: deburring, polish, spray paint, polish, pack.
Embodiment 3
The present invention provides the processing technique of a kind of eye glass frame containing negative oxygen ion, and detailed process is:
S10: adding negative oxygen ion powder in plastic cement titanium, wherein, be calculated in mass percent, the content of negative oxygen ion powder is
1%, it is calculated in mass percent, in negative oxygen ion powder:
Al2O3Content be 35.5%
SiO2Content be 35%
B2O3Content be 11%
The content of MgO is 4.7%
Fe2O3Content be 10.2%
Na2The content of O is 0.92%
K2The content of O is 0.04%
The content of CaO is 0.81%
P2O5Content be 0.22%
TiO2Content be 0.26%
The content of FeO is 1.35%；
The granularity of negative oxygen ion powder is 1250 mesh mix homogeneously；Mix homogeneously；
S20: note in punching block by injection machine by the mixture in step S10, is heated up to 130 DEG C and continues to go out for 50 seconds
Mould, cooling..
S30: deburring, polish, spray paint, polish, pack.
Embodiment 4
The present invention provides the processing technique of a kind of eye glass frame containing negative oxygen ion, and detailed process is:
S10: adding negative oxygen ion powder in plastic cement titanium, wherein, be calculated in mass percent, the content of negative oxygen ion powder is
1%, it is calculated in mass percent, in negative oxygen ion powder:
Al2O3Content be 34.96%
SiO2Content be 35%
B2O3Content be 13%
The content of MgO is 5%
Fe2O3Content be 9%
Na2The content of O is 0.8%
K2The content of O is 0.04%
The content of CaO is 0.5%
P2O5Content be 0.1%
TiO2Content be 0.1%
The content of FeO is 1.5%；
The granularity of negative oxygen ion powder is 1250 mesh mix homogeneously；Mix homogeneously；
S20: note in punching block by injection machine by the mixture in step S10, is heated up to 130 DEG C and continues to go out for 50 seconds
Mould, cooling..
S30: deburring, polish, spray paint, polish, pack.
Claims (10)
1. the eye glass frame containing negative oxygen ion, it is characterised in that: include plastic cement titanium and negative oxygen ion powder；Wherein, with
Mass percentage, the content of described negative oxygen ion powder is 1%～20%.
A kind of eye glass frame containing negative oxygen ion, it is characterised in that: include plastic cement titanium and bear
Oxonium ion powder；Wherein, being calculated in mass percent, the content of described negative oxygen ion powder is 2%～10%.
A kind of eye glass frame containing negative oxygen ion, it is characterised in that: include plastic cement titanium and bear
Oxonium ion powder；Wherein, being calculated in mass percent, the content of described negative oxygen ion powder is 3%～6%.
A kind of eye glass frame containing negative oxygen ion, it is characterised in that: it is calculated in mass percent,
In described negative oxygen ion powder:
Al2O3Content be 33%～38%
SiO2Content be 32%～36%
B2O3Content be 9%～13%
The content of MgO is 2%～6.5%
Fe2O3Content be 8%～12%
Na2The content of O is 0.7%～1.1%
K2The content of O is 0.01%～0.08%
The content of CaO is 0.5%～1.0%
P2O5Content be 0.1%～0.3%
TiO2Content be 0.1%～0.3%
The content of FeO is 0.9%～1.5%.
A kind of eye glass frame containing negative oxygen ion, it is characterised in that: it is calculated in mass percent,
In described negative oxygen ion powder:
Al2O3Content be 35%～36%
SiO2Content be 34%～35%
B2O3Content be 10%～11%
The content of MgO is 4%～5%
Fe2O3Content be 10%～11%
Na2The content of O is 0.85%～1.0%
K2The content of O is 0.03%～0.05%
The content of CaO is 0.7%～0.9%
P2O5Content be 0.15%～0.25%
TiO2Content be 0.2%～0.3%
The content of FeO is 1.2%～1.4%.
A kind of eye glass frame containing negative oxygen ion, it is characterised in that: described negative oxygen ion powder
Granularity is 1100～1300 mesh.
A kind of eye glass frame containing negative oxygen ion, it is characterised in that: described negative oxygen ion powder
Granularity is 1200～1280 mesh.
8. the processing technique of the eye glass frame containing negative oxygen ion, it is characterised in that: comprise the following steps:
S10: add negative oxygen ion powder, mix homogeneously in plastic cement titanium；
S20: modeling.
9. the processing technique of the eye glass frame of negative oxygen ion as claimed in claim 8, it is characterised in that: also include after modeling:
S30: deburring, polish, spray paint, polish, pack.
10. the processing technique of the eye glass frame of negative oxygen ion as claimed in claim 8, it is characterised in that: in described step S20
Modeling process, particularly as follows: note in punching block by injection machine after adding negative oxygen ion powder mix homogeneously in plastic cement titanium, is heated up to 100
～130 DEG C of lasting depanning, coolings in 30～50 seconds.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610712053.5A CN106094248B (en) | 2016-08-24 | 2016-08-24 | A kind of eye glass frame and its processing technology containing negative oxygen ion |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610712053.5A CN106094248B (en) | 2016-08-24 | 2016-08-24 | A kind of eye glass frame and its processing technology containing negative oxygen ion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106094248A true CN106094248A (en) | 2016-11-09 |
| CN106094248B CN106094248B (en) | 2019-02-26 |
Family
ID=57224759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610712053.5A Expired - Fee Related CN106094248B (en) | 2016-08-24 | 2016-08-24 | A kind of eye glass frame and its processing technology containing negative oxygen ion |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106094248B (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106773134A (en) * | 2017-03-02 | 2017-05-31 | 珠海大爱科技有限公司 | The spectacle frame that negative oxygen ion can be increased and the material that negative oxygen ion can be produced |
| CN108286683A (en) * | 2018-03-11 | 2018-07-17 | 哈尔滨医大眼科医疗科技开发有限公司 | A kind of hospital's operating lamp |
| WO2019084986A1 (en) * | 2017-11-06 | 2019-05-09 | 苏州菲博特环保科技有限公司 | Negative ion energy glasses |
| CN110082929A (en) * | 2019-04-28 | 2019-08-02 | 成都康源量子生物技术研究院 | A kind of preparation method of energy of a quantum glasses |
| CN111830729A (en) * | 2020-07-24 | 2020-10-27 | 上海富升商贸有限公司 | Preparation method of far infrared glasses |
| CN112812483A (en) * | 2020-12-31 | 2021-05-18 | 青岛中新华美塑料有限公司 | AS alloy material capable of releasing negative oxygen ions and preparation method and application thereof |
| CN112852146A (en) * | 2020-12-31 | 2021-05-28 | 青岛中新华美塑料有限公司 | PA alloy material capable of releasing negative oxygen ions and preparation method and application thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103317662A (en) * | 2013-05-28 | 2013-09-25 | 胡海鹏 | Method for manufacturing spectacle frame and forming mould thereof |
| CN203480150U (en) * | 2013-09-11 | 2014-03-12 | 唐卫东 | Negative oxygen ion healthcare glasses |
| CN104788981A (en) * | 2014-01-17 | 2015-07-22 | 葛家波 | High-molecular material with health care effect |
| CN105254839A (en) * | 2015-11-13 | 2016-01-20 | 深圳智卫宾生物科技有限公司 | High-springback sponge, preparation method and health care brassiere prepared from high-springback sponge |
| CN107505723A (en) * | 2017-08-24 | 2017-12-22 | 林昌纯 | A kind of glasses with health-care efficacy |
-
2016
- 2016-08-24 CN CN201610712053.5A patent/CN106094248B/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103317662A (en) * | 2013-05-28 | 2013-09-25 | 胡海鹏 | Method for manufacturing spectacle frame and forming mould thereof |
| CN203480150U (en) * | 2013-09-11 | 2014-03-12 | 唐卫东 | Negative oxygen ion healthcare glasses |
| CN104788981A (en) * | 2014-01-17 | 2015-07-22 | 葛家波 | High-molecular material with health care effect |
| CN105254839A (en) * | 2015-11-13 | 2016-01-20 | 深圳智卫宾生物科技有限公司 | High-springback sponge, preparation method and health care brassiere prepared from high-springback sponge |
| CN107505723A (en) * | 2017-08-24 | 2017-12-22 | 林昌纯 | A kind of glasses with health-care efficacy |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106773134A (en) * | 2017-03-02 | 2017-05-31 | 珠海大爱科技有限公司 | The spectacle frame that negative oxygen ion can be increased and the material that negative oxygen ion can be produced |
| WO2019084986A1 (en) * | 2017-11-06 | 2019-05-09 | 苏州菲博特环保科技有限公司 | Negative ion energy glasses |
| CN108286683A (en) * | 2018-03-11 | 2018-07-17 | 哈尔滨医大眼科医疗科技开发有限公司 | A kind of hospital's operating lamp |
| CN110082929A (en) * | 2019-04-28 | 2019-08-02 | 成都康源量子生物技术研究院 | A kind of preparation method of energy of a quantum glasses |
| CN111830729A (en) * | 2020-07-24 | 2020-10-27 | 上海富升商贸有限公司 | Preparation method of far infrared glasses |
| CN112812483A (en) * | 2020-12-31 | 2021-05-18 | 青岛中新华美塑料有限公司 | AS alloy material capable of releasing negative oxygen ions and preparation method and application thereof |
| CN112852146A (en) * | 2020-12-31 | 2021-05-28 | 青岛中新华美塑料有限公司 | PA alloy material capable of releasing negative oxygen ions and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106094248B (en) | 2019-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106094248A (en) | A kind of eye glass frame containing negative oxygen ion and processing technique thereof | |
| CN102061094A (en) | Mixed glue radiating infrared rays and emitting negative ions and respirator coated with same | |
| CN207693769U (en) | A kind of intelligent nano Graphene antibiosis health-care physiotherapeutic eyeshade | |
| CN107300784A (en) | Quantum biological picture frame and the quantum biological glasses using the picture frame | |
| CN204563320U (en) | A kind of magnetic medical health care face helmet | |
| CN107678184A (en) | Anion medical science glasses | |
| CN105079952A (en) | Eye paste with healthcare function | |
| CN204143093U (en) | Anti-radiation nano negative ion glasses | |
| CN108873381A (en) | Medical health care glasses | |
| CN205181593U (en) | Helmet vision health care appearance | |
| CN104605983A (en) | Cold compress massage eye patch | |
| US10520749B2 (en) | Eyeglasses having negative ions and protection/filter layers | |
| KR200476824Y1 (en) | A Functional Eye Bandage | |
| CN106943230A (en) | A kind of visual rehabilitation eyeshade | |
| CN213252615U (en) | High-red light structure capable of relieving myopia fatigue and eye physical therapy device | |
| KR101683238B1 (en) | A method of functionality glasses | |
| KR200491961Y1 (en) | Heating patch and massage patch using the same | |
| CN205181998U (en) | Electron acupuncture beauty mask | |
| CN204496126U (en) | A kind of radiation-proof healthcare glasses | |
| CN211096199U (en) | Biological fiber mask | |
| CN210514846U (en) | Glasses | |
| CN208851969U (en) | A kind of stifling eyeshade | |
| CN105998755A (en) | Mild-moxibustion medicine and mild-moxibustion apparatus for treating myopia and amblyopia | |
| CN202342289U (en) | Health-care eyeshade | |
| CN104644328A (en) | Jade eyeshade |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20190226 Termination date: 20210824 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |